These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 38621439)
1. Reducing Temperature of Fused Deposition Modelling 3D Printing for Linalool Fast Dissolving Oral Films by Increasing Printer Nozzle Diameter. Ehtezazi T; Kteich A; Abdulkarim R; Anderson V; Algellay M; McCloskey AP; Carter N; Roberts M; Assi S; Al-Jumeily D; Thompson M; Mohamed FA; Sarker SD J Pharm Sci; 2024 Aug; 113(8):2374-2382. PubMed ID: 38621439 [TBL] [Abstract][Full Text] [Related]
2. The Application of 3D Printing in the Formulation of Multilayered Fast Dissolving Oral Films. Ehtezazi T; Algellay M; Islam Y; Roberts M; Dempster NM; Sarker SD J Pharm Sci; 2018 Apr; 107(4):1076-1085. PubMed ID: 29208374 [TBL] [Abstract][Full Text] [Related]
3. The Use of Micro-Ribbons and Micro-Fibres in the Formulation of 3D Printed Fast Dissolving Oral Films. Algellay M; Roberts M; Bosworth L; Sarker SD; Fatokun AA; Ehtezazi T Pharmaceuticals (Basel); 2023 Jan; 16(1):. PubMed ID: 36678576 [TBL] [Abstract][Full Text] [Related]
4. Next Steps in 3D Printing of Fast Dissolving Oral Films for Commercial Production. Ehtezazi T; Algellay M; Hardy A Recent Pat Drug Deliv Formul; 2020; 14(1):5-20. PubMed ID: 31886755 [TBL] [Abstract][Full Text] [Related]
5. 3D printing of pharmaceutical oral solid dosage forms by fused deposition: The enhancement of printability using plasticised HPMCAS. Oladeji S; Mohylyuk V; Jones DS; Andrews GP Int J Pharm; 2022 Mar; 616():121553. PubMed ID: 35131354 [TBL] [Abstract][Full Text] [Related]
6. Low temperature fused deposition modeling (FDM) 3D printing of thermolabile drugs. Kollamaram G; Croker DM; Walker GM; Goyanes A; Basit AW; Gaisford S Int J Pharm; 2018 Jul; 545(1-2):144-152. PubMed ID: 29705104 [TBL] [Abstract][Full Text] [Related]
7. Mechanical properties of fused filament fabricated PEEK for biomedical applications depending on additive manufacturing parameters. Wang Y; Müller WD; Rumjahn A; Schmidt F; Schwitalla AD J Mech Behav Biomed Mater; 2021 Mar; 115():104250. PubMed ID: 33302091 [TBL] [Abstract][Full Text] [Related]
8. An investigation into the use of polymer blends to improve the printability of and regulate drug release from pharmaceutical solid dispersions prepared via fused deposition modeling (FDM) 3D printing. Alhijjaj M; Belton P; Qi S Eur J Pharm Biopharm; 2016 Nov; 108():111-125. PubMed ID: 27594210 [TBL] [Abstract][Full Text] [Related]
9. 3D Printing of Drug Nanocrystals for Film Formulations. Germini G; Peltonen L Molecules; 2021 Jun; 26(13):. PubMed ID: 34203406 [TBL] [Abstract][Full Text] [Related]
10. Simplification of fused deposition modeling 3D-printing paradigm: Feasibility of 1-step direct powder printing for immediate release dosage form production. Fanous M; Gold S; Muller S; Hirsch S; Ogorka J; Imanidis G Int J Pharm; 2020 Mar; 578():119124. PubMed ID: 32035253 [TBL] [Abstract][Full Text] [Related]
11. Preparation and evaluation of identifiable quick response (QR)-coded orodispersible films using 3D printer with directly feeding nozzle. Oh BC; Jin G; Park C; Park JB; Lee BJ Int J Pharm; 2020 Jun; 584():119405. PubMed ID: 32387310 [TBL] [Abstract][Full Text] [Related]
12. Influence of fused deposition modelling printing parameters on tablet disintegration times: a design of experiments study. Kreft K; Stanić T; Perhavec P; Dreu R; Lavrič Z Acta Pharm; 2023 Sep; 73(3):405-422. PubMed ID: 37708955 [TBL] [Abstract][Full Text] [Related]
13. Taguchi optimization of 3D printed short carbon fiber polyetherketoneketone (CFR PEKK). Rabinowitz A; DeSantis PM; Basgul C; Spece H; Kurtz SM J Mech Behav Biomed Mater; 2023 Sep; 145():105981. PubMed ID: 37481803 [TBL] [Abstract][Full Text] [Related]
14. Extrudability analysis of drug loaded pastes for 3D printing of modified release tablets. Zidan A; Alayoubi A; Coburn J; Asfari S; Ghammraoui B; Cruz CN; Ashraf M Int J Pharm; 2019 Jan; 554():292-301. PubMed ID: 30439491 [TBL] [Abstract][Full Text] [Related]
15. Extrusion-based 3D printing of oral solid dosage forms: Material requirements and equipment dependencies. Henry S; Samaro A; Marchesini FH; Shaqour B; Macedo J; Vanhoorne V; Vervaet C Int J Pharm; 2021 Apr; 598():120361. PubMed ID: 33571622 [TBL] [Abstract][Full Text] [Related]
16. Adaptation of pharmaceutical excipients to FDM 3D printing for the fabrication of patient-tailored immediate release tablets. Sadia M; Sośnicka A; Arafat B; Isreb A; Ahmed W; Kelarakis A; Alhnan MA Int J Pharm; 2016 Nov; 513(1-2):659-668. PubMed ID: 27640246 [TBL] [Abstract][Full Text] [Related]
17. Fabrication of timed-release indomethacin core-shell tablets for chronotherapeutic drug delivery using dual nozzle fused deposition modeling (FDM) 3D printing. Chung S; Zhang P; Repka MA Eur J Pharm Biopharm; 2023 Jul; 188():254-264. PubMed ID: 37201727 [TBL] [Abstract][Full Text] [Related]
18. Performance and paroxetine stability in tablets manufactured by fused deposition modelling-based 3D printing. Figueiredo S; Fernandes AI; Carvalho FG; Pinto JF J Pharm Pharmacol; 2022 Jan; 74(1):67-76. PubMed ID: 34591102 [TBL] [Abstract][Full Text] [Related]
20. Formulation of 3D Printed Tablet for Rapid Drug Release by Fused Deposition Modeling: Screening Polymers for Drug Release, Drug-Polymer Miscibility and Printability. Solanki NG; Tahsin M; Shah AV; Serajuddin ATM J Pharm Sci; 2018 Jan; 107(1):390-401. PubMed ID: 29066279 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]